Search research articles
Contact Us
Filters
Showing results (101-110 of 181) with videos related to
Page
of 19
Sort By:
Oncotarget
|
March 22, 2021
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
Leukemia & Lymphoma
|
February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors
Akash Mukherjee, Denái R Milton, Elias J Jabbour, et al.
Haematologica
|
May 14, 2016
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis
Koji Sasaki, Hagop Kantarjian, Elias Jabbour, et al.
Clinical Lymphoma & Myeloma
|
December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experience
Farhad Ravandi, Susan O'Brien, Dan Jones, et al.
International Journal of Hematology
|
February 22, 2018
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations
Kiran Naqvi, Jorge E Cortes, Raja Luthra, et al.
Molecular Cancer Research : MCR
|
March 4, 2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
Uri Rozovski, Srdana Grgurevic, Carlos Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
William Wierda, Susan O'Brien, Sijin Wen, et al.
Blood
|
October 22, 2009
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
John C Byrd, Thomas J Kipps, Ian W Flinn, et al.
Leukemia Research
|
February 16, 2006
Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome
Karen W L Yee, Jorge Cortes, Alessandra Ferrajoli, et al.
Leukemia & Lymphoma
|
May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 181) with videos related to
Sort By:
Page
of 19
Oncotarget
|
March 22, 2021
STAT3 induces the expression of GLI1 in chronic lymphocytic leukemia cells
Uri Rozovski, David M Harris, Ping Li, et al.
Leukemia & Lymphoma
|
February 28, 2022
Clinical outcome of allogeneic stem cell transplantation in patients with B-cell lymphoid malignancies following treatment with targeted small molecule inhibitors
Akash Mukherjee, Denái R Milton, Elias J Jabbour, et al.
Haematologica
|
May 14, 2016
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis
Koji Sasaki, Hagop Kantarjian, Elias Jabbour, et al.
Clinical Lymphoma & Myeloma
|
December 16, 2005
T-cell prolymphocytic leukemia: a single-institution experience
Farhad Ravandi, Susan O'Brien, Dan Jones, et al.
International Journal of Hematology
|
February 22, 2018
Characteristics and outcome of chronic myeloid leukemia patients with E255K/V BCR-ABL kinase domain mutations
Kiran Naqvi, Jorge E Cortes, Raja Luthra, et al.
Molecular Cancer Research : MCR
|
March 4, 2015
Aberrant LPL Expression, Driven by STAT3, Mediates Free Fatty Acid Metabolism in CLL Cells
Uri Rozovski, Srdana Grgurevic, Carlos Bueso-Ramos, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 16, 2005
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia
William Wierda, Susan O'Brien, Sijin Wen, et al.
Blood
|
October 22, 2009
Phase 1/2 study of lumiliximab combined with fludarabine, cyclophosphamide, and rituximab in patients with relapsed or refractory chronic lymphocytic leukemia
John C Byrd, Thomas J Kipps, Ian W Flinn, et al.
Leukemia Research
|
February 16, 2006
Triapine and cytarabine is an active combination in patients with acute leukemia or myelodysplastic syndrome
Karen W L Yee, Jorge Cortes, Alessandra Ferrajoli, et al.
Leukemia & Lymphoma
|
May 15, 2024
Long-term results of the sequential combination of cladribine and rituximab in Hairy cell leukemia
Jennifer Marvin-Peek, Wei-Ying Jen, Hagop M Kantarjian, et al.
Page
of 19